The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJDS.L Regulatory News (JDS)

  • There is currently no data for JDS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

9 Apr 2020 10:21

RNS Number : 3649J
Mandarin Oriental International Ltd
09 April 2020
 

The following announcement has been issued to a Regulatory Information Service approved by the Financial Conduct Authority in the United Kingdom.

 

MANDARIN ORIENTAL INTERNATIONAL LIMITED

Interim Management Statement

 

9th April 2020 - Mandarin Oriental International Limited today issues its Interim Management Statement for the first quarter of 2020.

 

The Group's performance was severely impacted by the COVID-19 pandemic, resulting in an unaudited underlying loss of some US$40 million in the first quarter. A majority of the Group's hotels are now effectively closed and, while most hotels in Asia remain open, they are experiencing single digit percentage occupancy levels.

 

The Group has taken a number of actions to manage costs and preserve cash. These include the suspension of non-essential expenses and capital expenditure, significantly reducing payroll costs through unpaid leave, furloughing, substantial voluntary salary reductions at all levels and participation in government support measures wherever possible. The payroll measures have been taken proportionate to the seniority and means of colleagues. The Directors would like to express their deep gratitude for the continuing dedication and resolve of colleagues during these difficult times.

 

It is too early to forecast the duration of the impact of COVID-19 on the business but, as a result of the substantial reduction in revenue and management fees from the Group's hotels, the underlying loss in the second quarter is expected to be larger than in the first quarter.

 

In light of the exceptional circumstances, the Directors have withdrawn their recommendation of a final dividend in respect of the 2019 financial year and the relevant resolution seeking approval for the payment of the dividend will no longer be put to shareholders at the Company's AGM on 6th May 2020.

 

The Group's balance sheet and liquidity position both remain strong and will enable it to sustain the current low levels of business activity for an extended period of time. At 31st March 2020, net debt was US$363 million compared to net debt of US$300 million at the end of 2019. Gearing was 6% of adjusted shareholders' funds. During the quarter, the Group invested US$19 million in the restoration of Mandarin Oriental Ritz, Madrid.

 

At 31st March 2020, in addition to US$229 million of cash reserves, the Group also had US$207 million in available debt facilities that are committed for four years. The Group's facilities are not subject to any cash flow covenants.

 

While the Group's operations are currently being dramatically impacted by events associated with the COVID-19 pandemic, Mandarin Oriental remains a powerful brand that is well positioned to benefit over the long-term, when demand for luxury travel returns.

 

Mandarin Oriental International Limited is incorporated in Bermuda and has a standard listing on the London Stock Exchange, with secondary listings in Bermuda and Singapore. It is a member of the Jardine Matheson Group.

 

- end -

 

For further information, please contact:

 

Mandarin Oriental Hotel Group International Limited

James Riley (852) 2895 9288

Craig Beattie (852) 2895 9288

Brunswick Group Limited

David Ashton (852) 3512 5063

 

This and other Group announcements can be accessed through the Internet at 'www.mandarinoriental.com'.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DOCKKLBBBZLFBBV
Date   Source Headline
10th May 201812:34 pmRNSInterim Management Statement
9th May 201812:35 pmRNSInterim Management Statement
9th May 201812:34 pmRNSInterim Management Statement
9th May 201812:32 pmRNSInterim Management Statement
2nd May 201810:16 amRNSDividend
30th Apr 201810:33 amRNSDividend
27th Apr 201810:44 amRNSFirst Quarter 2018 Results of PT Hero
26th Apr 201810:38 amRNSJC&C 2018 First Quarter Financial Statements
24th Apr 201810:37 amRNSPT Astra 2018 First Quarter Financial Statements
12th Apr 201811:17 amRNSAnnual Financial Report
6th Apr 201810:58 amRNSShares Purchase
4th Apr 201810:11 amRNSCirc re. Scrip Dividend Scheme
3rd Apr 201810:50 amRNSShares Purchase
3rd Apr 20187:00 amRNSShares Purchase
28th Mar 201812:01 pmRNSShares Purchase
27th Mar 201811:27 amRNSShares Purchase
23rd Mar 20189:14 amRNSDF to Partner with Robinsons in the Philippines
8th Mar 20189:23 amRNS2017 Preliminary Announcement of Results
8th Mar 20189:19 amRNS2017 Preliminary Announcement of Results
8th Mar 20189:09 amRNS2017 PRELIMINARY ANNOUNCEMENT OF RESULTS
8th Mar 20189:08 amRNS2017 PRELIMINARY ANNOUNCEMENT OF RESULTS
8th Mar 20189:07 amRNS2017 PRELIMINARY ANNOUNCEMENT OF RESULTS
1st Mar 20189:32 amRNSFull Year 2017 Results of PT Hero
1st Mar 20189:13 amRNSJC&C 2017 Financial Statements
27th Feb 20189:47 amRNSPT Astra - 2017 Full Year Financial Statements
7th Feb 20189:11 amRNSNotice of 2017 Final Results
5th Feb 201810:51 amRNSShares Purchase
1st Feb 201810:34 amRNSShares Purchase
17th Jan 201811:06 amRNSShares Purchase
15th Jan 201810:46 amRNSShares Purchase
11th Jan 201810:28 amRNSShares Purchase
9th Nov 20179:09 amRNSInterim Management Statement
9th Nov 20179:08 amRNSInterim Management Statement
8th Nov 20179:15 amRNSJC&C 2017 Third Quarter Financial Statements
31st Oct 20179:39 amRNSPT Astra Tbk 2017 3rd Quarter Financial Statement
31st Oct 20179:19 amRNSTotal Voting Rights
27th Oct 201710:46 amRNSNine Months 2017 Results of PT Hero
19th Oct 20171:41 pmRNSDirector/PDMR Shareholding
13th Oct 201710:11 amRNSAdditional Listing
6th Oct 20177:00 amRNSShares Purchase
4th Oct 201710:12 amRNSDividend
29th Sep 201712:00 pmRNSShares Purchase
29th Sep 201711:16 amRNSDividend
28th Sep 201711:59 amRNSShares Purchase
27th Sep 20177:31 amRNSUpdate Review:Long-term Strategic Options for EXHK
15th Sep 201710:11 amRNSMO-Review of Long-term Strategic Options for EXHK
14th Sep 201710:46 amRNSShares Purchase
12th Sep 201711:38 amRNSShares Purchases
8th Sep 201711:35 amRNSShares Purchase
7th Sep 201711:12 amRNSShare Purchase

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.